Canlyniadau Chwilio - Allan Lipton

Mireinio'r Canlyniadau
  1. 1
    Bisphosphonates and breast carcinoma

    Bisphosphonates and breast carcinoma gan Allan Lipton

    Cyhoeddwyd 1997
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Medical adrenalectomy using aminoglutethimide and dexamethasone in advanced breast cancer

    Medical adrenalectomy using aminoglutethimide and dexamethasone in advanced breast cancer gan Allan Lipton, Richard J. Santen

    Cyhoeddwyd 1974
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Serum Factor Requirements of Normal and Simian Virus 40-Transformed 3T3 Mouse Fibroblasts

    Serum Factor Requirements of Normal and Simian Virus 40-Transformed 3T3 Mouse Fibroblasts gan Dieter Paul, Allan Lipton, Ingrid Klinger

    Cyhoeddwyd 1971
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Urinary polyamine levels in human cancer

    Urinary polyamine levels in human cancer gan Allan Lipton, Linda Sheehan, Georg Frederick Kessler

    Cyhoeddwyd 1975
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Zoledronic acid delays the onset of skeletal‐related events and progression of skeletal disease in patients with advanced renal cell carcinoma

    Zoledronic acid delays the onset of skeletal‐related events and progression of skeletal disease in patients with advanced renal cell carcinoma gan Allan Lipton, Ming Zheng, John J. Seaman

    Cyhoeddwyd 2003
    Cael y testun llawn Cael y testun llawn
    Carta
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Biochemical markers and skeletal metastases

    Biochemical markers and skeletal metastases gan Laurence M. Demers, Luís Costa, Allan Lipton

    Cyhoeddwyd 2000
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Migration of Mouse 3T3 Fibroblasts in Response to a Serum Factor

    Migration of Mouse 3T3 Fibroblasts in Response to a Serum Factor gan Allan Lipton, Ingrid Klinger, Dieter Paul, Robert W. Holley

    Cyhoeddwyd 1971
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Oral bisphosphonates

    Oral bisphosphonates gan Pierre Major, Allan Lipton, James R. Berenson, Gabriel N. Hortobágyi

    Cyhoeddwyd 2000
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Serum Lactate Dehydrogenase Is Prognostic for Survival in Patients with Bone Metastases from Breast Cancer: A Retrospective Analysis in Bisphosphonate-Treated Patients

    Serum Lactate Dehydrogenase Is Prognostic for Survival in Patients with Bone Metastases from Breast Cancer: A Retrospective Analysis in Bisphosphonate-Treated Patients gan Janet E. Brown, Richard J. Cook, Allan Lipton, Robert E. Coleman

    Cyhoeddwyd 2012
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Zoledronic acid and skeletal complications in patients with solid tumors and bone metastases

    Zoledronic acid and skeletal complications in patients with solid tumors and bone metastases gan Hind T. Hatoum, Swu‐Jane Lin, Matthew Ryan Smith, Victoria Barghout, Allan Lipton

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    A phase-I trial of the epidermal growth factor receptor directed bispecific antibody MDX-447 without and with recombinant human granulocyte-colony stimulating factor in patients with advanced solid tumors

    A phase-I trial of the epidermal growth factor receptor directed bispecific antibody MDX-447 without and with recombinant human granulocyte-colony stimulating factor in patients wi... gan Matthew G. Fury, Allan Lipton, Katherine Smith, Corinne Winston, David G. Pfister

    Cyhoeddwyd 2007
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Prognostic factors for skeletal complications from metastatic bone disease in breast cancer

    Prognostic factors for skeletal complications from metastatic bone disease in breast cancer gan Janet E. Brown, Richard J. Cook, Allan Lipton, Luís Costa, Robert E. Coleman

    Cyhoeddwyd 2010
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    A comparative trial of transsphenoidal hypophysectomy and estrogen suppression with aminoglutethimide in advanced breast cancer

    A comparative trial of transsphenoidal hypophysectomy and estrogen suppression with aminoglutethimide in advanced breast cancer gan Harold A. Harvey, Richard J. Santen, Juraj Osterman, E Samojlik, Deborah S. White, Allan Lipton

    Cyhoeddwyd 1979
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Biochemical markers of bone turnover in patients with metastatic bone disease

    Biochemical markers of bone turnover in patients with metastatic bone disease gan L. M. Demers, Luís Costa, Vernon M. Chinchilli, L. Gaydos, E Curley, Allan Lipton

    Cyhoeddwyd 1995
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Skeletal Complications in Patients with Bone Metastases from Renal Cell Carcinoma and Therapeutic Benefits of Zoledronic Acid

    Skeletal Complications in Patients with Bone Metastases from Renal Cell Carcinoma and Therapeutic Benefits of Zoledronic Acid gan Allan Lipton, Alejandro Colombo-Berra, Ronald M. Bukowski, Lee S. Rosen, Ming Zheng, Gladys Urbanowitz

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Synergistic Inhibition with a Dual Epidermal Growth Factor Receptor/HER-2/neu Tyrosine Kinase Inhibitor and a Disintegrin and Metalloprotease Inhibitor

    Synergistic Inhibition with a Dual Epidermal Growth Factor Receptor/HER-2/neu Tyrosine Kinase Inhibitor and a Disintegrin and Metalloprotease Inhibitor gan Lois Witters, Peggy Scherle, Steven Friedman, Jordan S. Fridman, Eian Caulder, Robert Newton, Allan Lipton

    Cyhoeddwyd 2008
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Potential Clinical Utility of Serum HER-2/neu Oncoprotein Concentrations in Patients with Breast Cancer

    Potential Clinical Utility of Serum HER-2/neu Oncoprotein Concentrations in Patients with Breast Cancer gan Walter P. Carney, Rainer Neumann, Allan Lipton, Kim Leitzel, Suhail M. Ali, Christopher P. Price

    Cyhoeddwyd 2003
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Pathologic fractures correlate with reduced survival in patients with malignant bone disease

    Pathologic fractures correlate with reduced survival in patients with malignant bone disease gan Fred Saad, Allan Lipton, Richard J. Cook, Yin‐Miao Chen, Matthew R. Smith, Robert E. Coleman

    Cyhoeddwyd 2007
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Glycoproteins and human cancer:1. Circulating levels in cancer serum

    Glycoproteins and human cancer:1. Circulating levels in cancer serum gan Allan Lipton, Harold A. Harvey, Sally Delong, Joseph C. Allegra, Deborah S. White, Marilyn Allegra, Eugene A. Davidson

    Cyhoeddwyd 1979
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer

    Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer gan MICHAEL S. KOPRESKI, Floyd A. Benko, Chee Kwee, Kim Leitzel, Emad F. Eskander, Allan Lipton, Christopher D. Gocke

    Cyhoeddwyd 1997
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: